Description:
Summary:As Senior Director, Intellectual Property, you will serve as a key legal advisor and strategic partner to our R&D, CMC, and Tech Ops teams. You will be responsible for all aspects of IP management, including patent prosecution, freedom-to-operate analysis, competitive IP intelligence, IP litigation, and IP-related transactions, with a focus on technologies central to radioligand therapies such as ligand design, radionuclide conjugation, isotope production, and radiochemistry.
Key Responsibilities:
- Develop and implement IP strategies for protecting innovations across the RLT platform, including ligands, chelators, linkers, isotopes, targeting vectors, and manufacturing processes
- Manage and grow the company's global patent portfolio, including drafting and prosecution
- Conduct and supervise freedom-to-operate (FTO), patentability, and landscape analyses in collaboration with R&D and corporate strategy
- Provide strategic IP input into clinical and regulatory activities, including IND and BLA submissions, and assess potential third-party IP risks
- Manage and provide strategic direction on all IP litigation, including actions before the USPTO and oppositions
- Advise on IP-related aspects of business development, including due diligence for licensing, collaboration, and acquisition opportunities
- Manage and collaborate with external patent counsel and ensure timely and cost-effective handling of IP matters
- Draft, review, and negotiate IP provisions in agreements, including licensing, collaborations, sponsored research, MTAs and CDAs
- Train and inform scientists and senior management on IP awareness and strategy
- Provide support and gain experience on legal matters outside of IP including contracts, corporate governance, employment, and business development transactions.
- Travel to Oslo, Norway as needed
Qualifications:
- J.D. from an accredited law school and admission to practice in at least one U.S. jurisdiction
- Registered to practice before the U.S. Patent and Trademark Office (USPTO)
- 5–10+ years of relevant experience in patent law, with strong exposure to the biopharma industry
- Ph.D. in chemistry, radiochemistry, biochemistry, bioengineering, or a related life science discipline is preferred
- Experience with radiopharmaceuticals is highly desirable
- Demonstrated ability to align IP strategy with scientific, clinical and commercial goals in a fast-paced, innovative environment
Preferred Experience:
- Prior law firm experience
- In-house experience at a biotech or pharmaceutical company
- Knowledge of isotope supply chains, CMO partnerships, and manufacturing of radiopharmaceuticals
- Strong cross-cultural communication skills and the ability to adapt to a dynamic international team setting
- Experience with patent law in jurisdictions outside of the U.S.